Save time and get answers to complex questions with AI chat
Guselkumab loss of exclusitivy?Tracleer online pharmacy?Can wine consumption affect lipitor's cholesterol lowering ability?Stribild expiry date?Patent tenofovir alafenamide gilead?
See the DrugPatentWatch profile for Stiolto
Stiolto is a chronic obstructive pulmonary disease (COPD) inhaler that contains two active ingredients: tiotropium and olodaterol. [1]
Tiotropium is a long-acting antimuscarinic (LAMA). It helps relax the airway muscles by blocking muscarinic receptors, which can reduce bronchoconstriction. [1] Olodaterol is a long-acting beta2-agonist (LABA). It relaxes airway smooth muscle by stimulating beta2 receptors. [1]
Stiolto combines a LAMA (tiotropium) and a LABA (olodaterol) to provide bronchodilation through two different mechanisms, aimed at improving airflow and helping manage COPD symptoms. [1]
Yes. Many COPD inhalers use one long-acting bronchodilator (either LAMA or LABA) or different combinations. The defining feature of Stiolto is that it specifically pairs tiotropium + olodaterol. [1]
[1] https://www.drugs.com/stiolto.html
Other Questions About Stiolto :